Organization and Significant Accounting Policies (Details) - USD ($)			12 Months Ended
	Apr. 15, 2025	Mar. 06, 2024	Dec. 31, 2025	Dec. 31, 2024	May 25, 2005
Organization and Significant Accounting Policies [Line Items]
Cash and cash equivalents			$ 345,112	$ 626,879
Accumulated deficit			(47,214,235)	(44,026,679)
Working capital deficit			5,100,000
Net losses			(3,187,556)	(4,736,365)
Cash inflows from operating activities			70,000.00
Advanced additional amount			260,000
Aggregate value			1,435,136	1,144,985
Reverse stock split	1-for-10	1-for-5
Charges to credit losses			4,029	5,072
Uncollectible trade accounts receivable balances			13,878,582	0
Inventory written off			$ 549,218	450,738
Initial term of leases			12 months
Contract liabilities			$ 111,580	$ 162,208
China Pharma [Member]
Organization and Significant Accounting Policies [Line Items]
Reverse stock split	1-for -10
Onny Investment Limited [Member]
Organization and Significant Accounting Policies [Line Items]
Ownership percentage			100.00%
Hainan Helpson Medical & Biotechnology Co., Ltd [Member]
Organization and Significant Accounting Policies [Line Items]
Ownership percentage			100.00%		100.00%
Share-Based Payment Arrangement, Option [Member]
Organization and Significant Accounting Policies [Line Items]
Potentially dilutive common shares (in Shares)			13,300